Skip to content
drillr.ai

CLPT

ClearPoint Neuro, Inc.

NASDAQ · USHealthcareMedical - Devices
$15.05-0.66%

Price as of Jul 20, 2026

CLPT news

ClearPoint Neuro, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

    Announcement is made after successful proof-of-concept trial in a preclinical model of intravenous delivery of large molecule tracers across the blood-brain barrier guided by prototype systems, including both focused ultrasound hardware and ClearPoint Navigation Software and Robotics SOLANA BEACH, CA / ACCESS Newswire (https://www.accessnewswire.com/) / May 27, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling company offering precise navi

    ACCESSWIRE ·

  2. ClearPoint Neuro Reports First Quarter 2026 Results

    Record Revenue Achieved Including 25% Organic Growth in Devices and 43% Overall Growth SOLANA BEACH, CA / ACCESS Newswire (https://www.accessnewswire.com/) / May 13, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced financial results for its first quarter ended March 31, 2026. First Quarter 2026 Highlights * Reported first quarter revenue of $12.1 million, inc

    ACCESSWIRE ·

  3. ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint

    SOLANA BEACH, CA / ACCESS Newswire (https://www.accessnewswire.com/) / May 13, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that the Velocity Alpha(®) MR High Speed Surgical Drill System has received CE Marking in addition to the existing FDA 510(k) clearance in the United States. The Velocity Alpha MR High Speed Surgical Drill System is manufactured by German

    ACCESSWIRE ·

  4. ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

    SOLANA BEACH, CA / ACCESS Newswire (https://www.accessnewswire.com/) / April 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced the successful completion of the first clinical procedure utilizing the 510(k)-cleared Velocity Alpha MR High Speed Surgical Drill System. Utilized in a four-trajectory clinical trial procedure, the system highlights its scalability and

    ACCESSWIRE ·

  5. ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026

    SOLANA BEACH, CA / ACCESS Newswire (https://www.accessnewswire.com/) / March 6, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will release financial results for its 2025 fourth quarter and full year on Tuesday, March 17th, after the market close. Investors and analysts are invited to listen to the live broadcast review of the Company's 2025 fourth qu

    ACCESSWIRE ·